HK Stock MarketDetailed Quotes
06990 SKB BIO-B
- 161.500
- -4.100-2.48%
Market Closed Nov 15 16:08 CST
35.99BMarket Cap-141048P/E (TTM)
177.200High160.600Low396.41KVolume164.300Open165.600Pre Close65.94MTurnover0.30%Turnover RatioLossP/E (Static)222.84MShares223.80052wk High10.24P/B21.23BFloat Cap63.65052wk Low--Dividend TTM131.43MShs Float223.800Historical High--Dividend LFY10.02%Amplitude60.600Historical Low166.347Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
SKB BIO-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|
| Turnover | 32.17%1.38B | 91.62%1.54B | --1.05B | 2,387.26%803.93M | 2,266.02%623.99M | --32.32M | --26.37M |
| Operating income | 32.17%1.38B | 91.62%1.54B | 1.05B | 2,387.26%803.93M | 2,266.02%623.99M | 32.32M | 26.37M |
| Cost of sales | 17.40%-306.1M | -182.24%-781.31M | ---370.57M | -1,248.74%-276.83M | -991.51%-182.76M | ---20.53M | ---16.74M |
| Operating expenses | 17.40%-306.1M | -182.24%-781.31M | -370.57M | -1,248.74%-276.83M | -991.51%-182.76M | -20.53M | -16.74M |
| Gross profit | 59.35%1.08B | 44.03%759.19M | 675.66M | 4,368.13%527.11M | 4,482.29%441.23M | 11.8M | 9.63M |
| Selling expenses | ---41.15M | ---19.53M | ---- | ---- | ---- | ---- | ---- |
| Administrative expenses | 26.37%-65.84M | -90.84%-181.88M | ---89.42M | 0.91%-95.3M | 17.88%-63.59M | ---96.17M | ---77.44M |
| Research and development expenses | -33.04%-652.34M | -21.87%-1.03B | ---490.35M | -16.26%-845.98M | 3.58%-513.62M | ---727.67M | ---532.68M |
| Special items of operating profit | 291.36%94.4M | 2,156.07%89.81M | --24.12M | -112.54%-4.37M | -228.96%-28.09M | --34.84M | --21.78M |
| Operating profit | 243.11%411.76M | 8.40%-383.38M | 120.01M | 46.15%-418.55M | 71.65%-164.08M | -777.2M | -578.7M |
| Financing cost | 96.82%-2.51M | 43.35%-84.31M | ---78.73M | -32.17%-148.81M | -38.98%-110.43M | ---112.59M | ---79.46M |
| Earning before tax | 891.47%409.25M | 17.57%-467.69M | 41.28M | 36.24%-567.36M | 58.29%-274.51M | -889.8M | -658.16M |
| Tax | -36.76%-99.03M | -118.41%-106.44M | ---72.41M | ---48.74M | ---46.72M | ---- | ---- |
| After-tax profit from continuing operations | 1,096.55%310.23M | 6.81%-574.13M | -31.13M | 30.76%-616.1M | 51.19%-321.23M | -889.8M | -658.16M |
| Earning after tax | 1,096.55%310.23M | 6.81%-574.13M | -31.13M | 30.76%-616.1M | 51.19%-321.23M | -889.8M | -658.16M |
| Profit attributable to shareholders | 1,096.55%310.23M | 6.81%-574.13M | -31.13M | 30.76%-616.1M | 51.19%-321.23M | -889.8M | -658.16M |
| Basic earnings per share | 929.41%1.41 | 50.52%-2.84 | -0.17 | 35.51%-5.74 | 55.70%-2.99 | -8.9 | -6.75 |
| Diluted earnings per share | 929.41%1.41 | 50.52%-2.84 | -0.17 | 35.51%-5.74 | 55.70%-2.99 | -8.9 | -6.75 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | IAS | HKAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data